Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Arrestin recruitment to dopamine D2 receptor mediates locomotion but not incentive motivation
Prashant Donthamsetti, Eduardo F. Gallo, David C. Buck, et al.
Molecular Psychiatry (2018) Vol. 25, Iss. 9, pp. 2086-2100
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Dopamine and Dopamine Receptors in Alzheimer's Disease: A Systematic Review and Network Meta-Analysis
Xiongfeng Pan, Atipatsa Chiwanda Kaminga, Shi Wu Wen, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 200
Role of heavy metals (copper (Cu), arsenic (As), cadmium (Cd), iron (Fe) and lithium (Li)) induced neurotoxicity
Balachandar Vellingiri, Atchaya Suriyanarayanan, Priyanka Selvaraj, et al.
Chemosphere (2022) Vol. 301, pp. 134625-134625
Closed Access | Times Cited: 70
β−Arrestins: Structure, Function, Physiology, and Pharmacological Perspectives
Jürgen Wess, Antwi‐Boasiako Oteng, Osvaldo Rivera‐Gonzalez, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 854-884
Open Access | Times Cited: 54
Dopamine: an immune transmitter
Alessandro Castorina, Sarah Thomas Broome, Krystal Louangaphay, et al.
Neural Regeneration Research (2020) Vol. 15, Iss. 12, pp. 2173-2173
Open Access | Times Cited: 88
Behavioral alterations in antibiotic-treated mice associated with gut microbiota dysbiosis: insights from 16S rRNA and metabolomics
Asma Bibi, Famin Zhang, Jilong Shen, et al.
Frontiers in Neuroscience (2025) Vol. 19
Open Access | Times Cited: 1
Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
Mikkel Søes Ibsen, David B. Finlay, Monica Patel, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 74
2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts
Amy Hauck Newman, Francisco O. Battiti, Alessandro Bonifazi
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 5, pp. 1779-1797
Open Access | Times Cited: 62
Come Fly with Me: An overview of dopamine receptors in Drosophila melanogaster
Caline S. Karam, Sandra K. Jones, Jonathan A. Javitch
Basic & Clinical Pharmacology & Toxicology (2019) Vol. 126, Iss. S6, pp. 56-65
Open Access | Times Cited: 61
Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds
Elise Wouters, Jolien Walraed, Michael J. Robertson, et al.
ACS Pharmacology & Translational Science (2019) Vol. 3, Iss. 2, pp. 285-295
Open Access | Times Cited: 56
A golden age of muscarinic acetylcholine receptor modulation in neurological diseases
Andrew B. Tobin
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 10, pp. 743-758
Closed Access | Times Cited: 6
A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity
Marta Sánchez‐Soto, Ravi Kumar Verma, Blair K. A. Willette, et al.
Science Signaling (2020) Vol. 13, Iss. 617
Open Access | Times Cited: 41
Causal Link between n-3 Polyunsaturated Fatty Acid Deficiency and Motivation Deficits
Fabien Ducrocq, Roman Walle, A. Contini, et al.
Cell Metabolism (2020) Vol. 31, Iss. 4, pp. 755-772.e7
Open Access | Times Cited: 39
How changes in dopamine D2 receptor levels alter striatal circuit function and motivation
Eleanor H. Simpson, Eduardo F. Gallo, Peter D. Balsam, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 436-444
Open Access | Times Cited: 37
Dopamine D2 receptors modulate the cholinergic pause and inhibitory learning
Eduardo F. Gallo, Julia Greenwald, Jenna Yeisley, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 3, pp. 1502-1514
Open Access | Times Cited: 33
Cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors
Prashant Donthamsetti, Nils Winter, Adam Hoagland, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 32
The complex molecular pharmacology of the dopamine D2 receptor: Implications for pramipexole, ropinirole, and rotigotine
Mattia Ferraiolo, Emmanuel Hermans
Pharmacology & Therapeutics (2023) Vol. 245, pp. 108392-108392
Closed Access | Times Cited: 15
Ligand-Induced Biased Activation of GPCRs: Recent Advances and New Directions from In Silico Approaches
Shaima Hashem, Alexis Dougha, Pierre Tufféry
Molecules (2025) Vol. 30, Iss. 5, pp. 1047-1047
Open Access
Inhibition of Colony-Stimulating Factor 1 Receptor by PLX3397 Prevents Amyloid Beta Pathology and Rescues Dopaminergic Signaling in Aging 5xFAD Mice
Yeonghoon Son, Ye Ji Jeong, Na‐Rae Shin, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5553-5553
Open Access | Times Cited: 38
Computational Studies Applied to Linalool and Citronellal Derivatives Against Alzheimer's and Parkinson's Disorders: A Review with Experimental Approach
Pablo Rayff da Silva, Jéssica Andrade, Natália Ferreira de Sousa, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 4, pp. 842-866
Open Access | Times Cited: 12
The histamine H3 receptor modulates dopamine D2 receptor–dependent signaling pathways and mouse behaviors
Jian Xu, Christopher Pittenger
Journal of Biological Chemistry (2023) Vol. 299, Iss. 4, pp. 104583-104583
Open Access | Times Cited: 11
Monoamine alterations in Alzheimer’s disease and their implications in comorbid neuropsychiatric symptoms
Shalini Saggu, Ava Bai, Mae Aida, et al.
GeroScience (2024)
Open Access | Times Cited: 4
Unveiling the Differences in Signaling and Regulatory Mechanisms between Dopamine D2 and D3 Receptors and Their Impact on Behavioral Sensitization
Kyeong‐Man Kim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6742-6742
Open Access | Times Cited: 10
Towards a multilevel model of major depression: genes, immuno-metabolic function, and cortico-striatal signaling
Elisabeth Paul, Margareta Östman, Markus Heilig, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Impact of membrane lipid polyunsaturation on dopamine D2 receptor ligand binding and signaling
Marie‐Lise Jobin, Véronique De Smedt‐Peyrusse, Fabien Ducrocq, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 5, pp. 1960-1969
Open Access | Times Cited: 9
A Gain‐of‐Function Variant in Dopamine D2 Receptor and Progressive Chorea and Dystonia Phenotype
Marlous C. M. van der Weijden, Dayana Rodriguez‐Contreras, Cathérine C.S. Delnooz, et al.
Movement Disorders (2020) Vol. 36, Iss. 3, pp. 729-739
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top